Skip to main content
Bioton S.A. logo

Bioton S.A. — Investor Relations & Filings

Ticker · BIO ISIN · PLBIOTN00029 LEI · 259400I5R1L3OPCGII81 WAR Manufacturing
Filings indexed 5 across all filing types
Latest filing 2025-04-01 Annual Report (ESEF)
Country PL Poland
Listing WAR BIO

About Bioton S.A.

https://bioton.com/en/

Bioton S.A. is a biotechnology company focused on providing comprehensive solutions for diabetes care. The company's core activity is the development and production of recombinant human insulin, positioning it as a significant commercial manufacturer globally. Its operations cover the full biotechnological process, from DNA research and development to the manufacturing and marketing of finished medicinal products. The product portfolio is centered on various forms of insulin and is complemented by modern automatic injection systems designed to facilitate effective diabetes treatment for patients.

Recent filings

Filing Released Lang Actions
Skonsolidowane sprawozdanie finansowe
Annual Report (ESEF) Classification · 100% confidence FY 2024
2025-04-01 Polish
Skonsolidowane sprawozdanie finansowe
Annual Report (ESEF) Classification · 100% confidence FY 2023
2024-03-28 Polish
Skonsolidowane sprawozdanie finansowe
Annual Report (ESEF) Classification · 100% confidence FY 2022
2023-03-31 Polish
Skonsolidowane sprawozdanie finansowe Grupy Kapitałowej Bioton
Annual Report (ESEF) Classification · 100% confidence FY 2021
2022-04-01 Polish
Skonsolidowane Sprawozdanie Finansowe Grupy kapitałowej Bioton S.A.
Annual Report (ESEF) Classification · 100% confidence FY 2020
2021-04-01 Polish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.